Austin Asset Management Co Inc Takes $315,000 Position in Nutex Health Inc. $NUTX

Austin Asset Management Co Inc purchased a new position in Nutex Health Inc. (NASDAQ:NUTXFree Report) in the second quarter, HoldingsChannel reports. The fund purchased 2,528 shares of the company’s stock, valued at approximately $315,000.

Other institutional investors also recently bought and sold shares of the company. KLP Kapitalforvaltning AS purchased a new stake in Nutex Health in the second quarter worth about $112,000. One Plus One Wealth Management LLC grew its holdings in Nutex Health by 3.3% in the second quarter. One Plus One Wealth Management LLC now owns 38,791 shares of the company’s stock worth $4,829,000 after purchasing an additional 1,250 shares during the period. Bank of America Corp DE grew its holdings in Nutex Health by 6,590.3% in the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock worth $66,000 after purchasing an additional 2,043 shares during the period. OMERS ADMINISTRATION Corp grew its holdings in Nutex Health by 28.8% in the first quarter. OMERS ADMINISTRATION Corp now owns 9,400 shares of the company’s stock worth $442,000 after purchasing an additional 2,100 shares during the period. Finally, Goldman Sachs Group Inc. grew its holdings in shares of Nutex Health by 17.9% during the first quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company’s stock valued at $852,000 after buying an additional 2,748 shares during the last quarter. 5.32% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

NUTX has been the topic of a number of recent analyst reports. Maxim Group set a $205.00 price target on shares of Nutex Health and gave the company a “buy” rating in a report on Tuesday, August 26th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Nutex Health in a report on Wednesday. Finally, Wall Street Zen upgraded shares of Nutex Health from a “hold” rating to a “strong-buy” rating in a report on Friday, September 26th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, Nutex Health currently has an average rating of “Moderate Buy” and a consensus target price of $252.50.

View Our Latest Report on Nutex Health

Nutex Health Trading Down 0.0%

Shares of NUTX stock opened at $102.74 on Thursday. Nutex Health Inc. has a 12-month low of $17.66 and a 12-month high of $184.27. The company has a current ratio of 2.27, a quick ratio of 2.26 and a debt-to-equity ratio of 1.02. The firm’s 50 day moving average is $93.88 and its 200 day moving average is $110.84. The stock has a market capitalization of $570.72 million, a P/E ratio of 8.64 and a beta of -0.20.

Nutex Health Profile

(Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

See Also

Want to see what other hedge funds are holding NUTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutex Health Inc. (NASDAQ:NUTXFree Report).

Institutional Ownership by Quarter for Nutex Health (NASDAQ:NUTX)

Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.